{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:38:27Z","timestamp":1793234307050,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41590-025-02363-9","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:02:14Z","timestamp":1767369734000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3996-2293","authenticated-orcid":false,"given":"Jaime A.","family":"Cardona-Ospina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-1098","authenticated-orcid":false,"given":"Vicky","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6826-9580","authenticated-orcid":false,"given":"Dorca E.","family":"Marcano-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-0336","authenticated-orcid":false,"given":"Sandra","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 V.","family":"Zambrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5717-4729","authenticated-orcid":false,"given":"Agamjot","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6018-2100","authenticated-orcid":false,"given":"Boyeong K.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4392-4206","authenticated-orcid":false,"suffix":"Jr","given":"Antonio Gregorio","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Zhiteneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8939-1971","authenticated-orcid":false,"given":"Julia","family":"Huffaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos J.","family":"Ramos-Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Balmaseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-9215","authenticated-orcid":false,"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-4037","authenticated-orcid":false,"given":"Eva","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"2363_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504\u2013507 (2013).","journal-title":"Nature"},{"key":"2363_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(23)02576-X","volume":"403","author":"G Paz-Bailey","year":"2024","unstructured":"Paz-Bailey, G., Adams, L. E., Deen, J., Anderson, K. B. & Katzelnick, L. C. Dengue. Lancet 403, 667\u2013682 (2024).","journal-title":"Lancet"},{"key":"2363_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 358, 929\u2013932 (2017).","journal-title":"Science"},{"key":"2363_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.abb6143","volume":"369","author":"LC Katzelnick","year":"2020","unstructured":"Katzelnick, L. C. et al. Zika virus infection enhances future risk of severe dengue disease. Science 369, 1123\u20131128 (2020).","journal-title":"Science"},{"key":"2363_CR5","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1126\/scitranslmed.adn2199","volume":"16","author":"JV Zambrana","year":"2024","unstructured":"Zambrana, J. V. et al. Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1. Sci. Transl. Med. 16, 2199 (2024).","journal-title":"Sci. Transl. Med."},{"key":"2363_CR6","doi-asserted-by":"publisher","first-page":"e0011710","DOI":"10.1371\/journal.pntd.0011710","volume":"17","author":"CF Estofolete","year":"2023","unstructured":"Estofolete, C. F. et al. Influence of previous Zika virus infection on acute dengue episode. PLoS Negl. Trop. Dis. 17, e0011710 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2363_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91793-0","volume":"11","author":"A Yamanaka","year":"2021","unstructured":"Yamanaka, A. et al. Antibody-dependent enhancement representing in vitro infective progeny virus titer correlates with the viremia level in dengue patients. Sci. Rep. 11, 12354 (2021).","journal-title":"Sci. Rep."},{"key":"2363_CR8","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/infdis\/jiz618","volume":"221","author":"JJ Waggoner","year":"2020","unstructured":"Waggoner, J. J. et al. Antibody-dependent enhancement of severe disease is mediated by serum viral load in pediatric dengue virus infections. J. Infect. Dis. 221, 1846\u20131854 (2020).","journal-title":"J. Infect. Dis."},{"key":"2363_CR9","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1126\/science.abc7303","volume":"372","author":"S Bournazos","year":"2021","unstructured":"Bournazos, S. et al. Antibody fucosylation predicts disease severity in secondary dengue infection. Science 372, 1102\u20131105 (2021).","journal-title":"Science"},{"key":"2363_CR10","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41564-023-01421-y","volume":"8","author":"R Yamin","year":"2023","unstructured":"Yamin, R. et al. Human Fc\u03b3RIIIa activation on splenic macrophages drives dengue pathogenesis in mice. Nat. Microbiol 8, 1468\u20131479 (2023).","journal-title":"Nat. Microbiol"},{"key":"2363_CR11","doi-asserted-by":"publisher","first-page":"e2462","DOI":"10.1371\/journal.pntd.0002462","volume":"7","author":"A Gordon","year":"2013","unstructured":"Gordon, A. et al. The Nicaraguan Pediatric Dengue Cohort Study: incidence of inapparent and symptomatic dengue virus infections, 2004\u20132010. PLoS Negl. Trop. Dis. 7, e2462 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2363_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S1473-3099(24)00566-8","volume":"25","author":"S Bos","year":"2025","unstructured":"Bos, S. et al. Serotype-specific epidemiological patterns of inapparent versus symptomatic primary dengue virus infections: a 17-year cohort study in Nicaragua. Lancet Infect. Dis. 25, 346\u2013356 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"2363_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/jcla.20172","volume":"21","author":"CT Perciani","year":"2007","unstructured":"Perciani, C. T., Peixoto, P. S., Dias, W. O., Kubrusly, F. S. & Tanizaki, M. M. Improved method to calculate the antibody avidity index. J. Clin. Lab. Anal. 21, 201\u2013206 (2007).","journal-title":"J. Clin. Lab. Anal."},{"key":"2363_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1203\/00006450-199001000-00004","volume":"27","author":"PG Shackelford","year":"1990","unstructured":"Shackelford, P. G., Granoff, D. M., Madassery, J. V., Scott, M. G. & Nahm, M. H. Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr. Res 27, 16\u201321 (1990).","journal-title":"Pediatr. Res"},{"key":"2363_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/BF01958271","volume":"149","author":"A Plebani","year":"1989","unstructured":"Plebani, A. et al. Serum IgG subclass concentrations in healthy subjects at different age: age normal percentile charts. Eur. J. Pediatr. 149, 164\u2013167 (1989).","journal-title":"Eur. J. Pediatr."},{"key":"2363_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13992-8","volume":"11","author":"U Steffen","year":"2020","unstructured":"Steffen, U. et al. IgA subclasses have different effector functions associated with distinct glycosylation profiles. Nat. Commun. 11, 120 (2020).","journal-title":"Nat. Commun."},{"key":"2363_CR17","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.4049\/jimmunol.2100924","volume":"209","author":"S Mayer-Hain","year":"2022","unstructured":"Mayer-Hain, S. et al. Systemic activation of neutrophils by immune complexes is critical to IgA vasculitis. J. Immun. 209, 1048\u20131058 (2022).","journal-title":"J. Immun."},{"key":"2363_CR18","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.3390\/jcm10112310","volume":"10","author":"E Pillebout","year":"2021","unstructured":"Pillebout, E. IgA vasculitis and IgA nephropathy: same disease? J. Clin. Med. 10, 2310 (2021).","journal-title":"J. Clin. Med."},{"key":"2363_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-pathmechdis-051222-015009","volume":"19","author":"A Aroca-Crevill\u00e9n","year":"2024","unstructured":"Aroca-Crevill\u00e9n, A., Vicanolo, T., Ovadia, S. & Hidalgo, A. Neutrophils in physiology and pathology. Annu Rev. Pathol. 19, 227\u2013259 (2024).","journal-title":"Annu Rev. Pathol."},{"key":"2363_CR20","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1126\/scitranslmed.abm3151","volume":"14","author":"AG Dias","year":"2022","unstructured":"Dias, A. G. et al. Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection. Sci. Transl. Med. 14, 3151 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2363_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/infdis\/jiaa789","volume":"223","author":"JR Strich","year":"2021","unstructured":"Strich, J. R. et al. Fostamatinib inhibits neutrophils extracellular traps induced by COVID-19 patient plasma: a potential therapeutic. J. Infect. Dis. 223, 981\u2013984 (2021).","journal-title":"J. Infect. Dis."},{"key":"2363_CR22","doi-asserted-by":"publisher","first-page":"e0012811","DOI":"10.1371\/journal.pntd.0012811","volume":"19","author":"F Narvaez","year":"2025","unstructured":"Narvaez, F. et al. Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua. PLoS Negl. Trop. Dis. 19, e0012811 (2025).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2363_CR23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/INF.0b013e3180619692","volume":"26","author":"JA Colbert","year":"2007","unstructured":"Colbert, J. A. et al. Ultrasound measurement of gallbladder wall thickening as a diagnostic test and prognostic indicator for severe dengue in pediatric patients. Pediatr. Infect. Dis. J. 26, 850\u2013852 (2007).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2363_CR24","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/jum.14890","volume":"38","author":"BDC Ferreira","year":"2019","unstructured":"Ferreira, B. D. C. & Correia, D. Ultrasound assessment of hepatobiliary and splenic changes in patients with dengue and warning signs during the acute and recovery phases. J. Ultrasound Med 38, 2015\u20132024 (2019).","journal-title":"J. Ultrasound Med"},{"key":"2363_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/01.inf.0000258612.26743.10","volume":"26","author":"A Srikiatkhachorn","year":"2007","unstructured":"Srikiatkhachorn, A. et al. Natural history of plasma leakage in dengue hemorrhagic fever. Pediatr. Infect. Dis. J. 26, 283\u2013290 (2007).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2363_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1473-3099(18)30718-7","volume":"19","author":"K Ruchusatsawat","year":"2019","unstructured":"Ruchusatsawat, K. et al. Long-term circulation of Zika virus in Thailand: an observational study. Lancet Infect. Dis. 19, 439\u2013446 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"2363_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00281-021-00878-5","volume":"43","author":"RC Monteiro","year":"2021","unstructured":"Monteiro, R. C. & Suzuki, Y. Are there animal models of IgA nephropathy? Semin. Immunopathol. 43, 639\u2013648 (2021).","journal-title":"Semin. Immunopathol."},{"key":"2363_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10875-024-01822-6","volume":"45","author":"G Seminario","year":"2024","unstructured":"Seminario, G. et al. The Latin American Society for Immunodeficiencies Registry. J. Clin. Immunol. 45, 28 (2024).","journal-title":"J. Clin. Immunol."},{"key":"2363_CR29","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1126\/scitranslmed.abf1555","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci. Transl. Med. 13, 1555 (2021).","journal-title":"Sci. Transl. Med."},{"key":"2363_CR30","doi-asserted-by":"publisher","first-page":"e1011616","DOI":"10.1371\/journal.ppat.1011616","volume":"19","author":"AD Wegman","year":"2023","unstructured":"Wegman, A. D. et al. DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection. PLoS Pathog. 19, e1011616 (2023).","journal-title":"PLoS Pathog."},{"key":"2363_CR31","first-page":"521","volume":"21","author":"BK Upadhaya","year":"2010","unstructured":"Upadhaya, B. K. et al. Transient IgA nephropathy with acute kidney injury in a patient with dengue fever. Saudi J. Kidney Dis. Transpl. 21, 521\u20135 (2010).","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"2363_CR32","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1007\/s00705-015-2519-7","volume":"160","author":"R Bachal","year":"2015","unstructured":"Bachal, R. et al. Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever. Arch. Virol. 160, 2435\u20132443 (2015).","journal-title":"Arch. Virol."},{"key":"2363_CR33","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/infdis\/jiac383","volume":"226","author":"PY Chia","year":"2022","unstructured":"Chia, P. Y., Teo, A. & Yeo, T. W. Association of neutrophil mediators with dengue disease severity and cardiac impairment in adults. J. Infect. Dis. 226, 1974\u20131984 (2022).","journal-title":"J. Infect. Dis."},{"key":"2363_CR34","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1371\/journal.pntd.0000710","volume":"4","author":"P Loke","year":"2010","unstructured":"Loke, P. et al. Gene expression patterns of dengue virus-infected children from Nicaragua reveal a distinct signature of increased metabolism. PLoS Negl. Trop. Dis. 4, e710 (2010).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2363_CR35","doi-asserted-by":"publisher","first-page":"e0011922","DOI":"10.1371\/journal.pntd.0011922","volume":"18","author":"M Recker","year":"2024","unstructured":"Recker, M. et al. Markers of prolonged hospitalisation in severe dengue. PLoS Negl. Trop. Dis. 18, e0011922 (2024).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2363_CR36","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.celrep.2019.01.033","volume":"26","author":"M Robinson","year":"2019","unstructured":"Robinson, M. et al. A 20-gene set predictive of progression to severe dengue. Cell Rep. 26, 1104\u20131111 (2019).","journal-title":"Cell Rep."},{"key":"2363_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01034-w","volume":"14","author":"YE Liu","year":"2022","unstructured":"Liu, Y. E. et al. An 8-gene machine learning model improves clinical prediction of severe dengue progression. Genome Med. 14, 33 (2022).","journal-title":"Genome Med."},{"key":"2363_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/jleuko\/qiad099","volume":"115","author":"S Duggal","year":"2024","unstructured":"Duggal, S. et al. Dengue virus infection in mice induces bone marrow myeloid cell differentiation and generates Ly6Glow immature neutrophils with modulated functions. J. Leukoc. Biol. 115, 130\u2013148 (2024).","journal-title":"J. Leukoc. Biol."},{"key":"2363_CR39","doi-asserted-by":"crossref","unstructured":"Stacey, H. D. et al. IgA potentiates NETosis in response to viral infection. Proc. Natl Acad. Sci. USA 118, e2101497118 (2021).","DOI":"10.1073\/pnas.2101497118"},{"key":"2363_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.761816","volume":"12","author":"A-K Gimpel","year":"2021","unstructured":"Gimpel, A.-K. et al. IgA complexes induce neutrophil extracellular trap formation more potently than IgG complexes. Front. Immunol. 12, 761816 (2021).","journal-title":"Front. Immunol."},{"key":"2363_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf199","volume":"12","author":"KC Allen","year":"2025","unstructured":"Allen, K. C. et al. SARS-CoV-2 immune complex\u2013mediated neutrophil activation. Open Forum Infect. Dis. 12, ofaf199 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"2363_CR42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/sciimmunol.aaw0336","volume":"4","author":"SL Knackstedt","year":"2019","unstructured":"Knackstedt, S. L. et al. Neutrophil extracellular traps drive inflammatory pathogenesis in malaria. Sci. Immunol. 4, 336 (2019).","journal-title":"Sci. Immunol."},{"key":"2363_CR43","doi-asserted-by":"publisher","first-page":"e1010247","DOI":"10.1371\/journal.ppat.1010247","volume":"18","author":"K Passelli","year":"2022","unstructured":"Passelli, K. et al. The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis. PLoS Pathog. 18, e1010247 (2022).","journal-title":"PLoS Pathog."},{"key":"2363_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.abc0476","volume":"371","author":"SB Biering","year":"2021","unstructured":"Biering, S. B. et al. Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction. Science 371, 194\u2013200 (2021).","journal-title":"Science"},{"key":"2363_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1126\/science.abb9425","volume":"371","author":"N Modhiran","year":"2021","unstructured":"Modhiran, N. et al. A broadly protective antibody that targets the flavivirus NS1 protein. Science 371, 190\u2013194 (2021).","journal-title":"Science"},{"key":"2363_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","volume":"19","author":"T N\u00e9meth","year":"2020","unstructured":"N\u00e9meth, T., Sperandio, M. & M\u00f3csai, A. Neutrophils as emerging therapeutic targets. Nat. Rev. Drug Discov. 19, 253\u2013275 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2363_CR47","unstructured":"Pan American Health Organization. Dengue and Dengue Hemorrhagic Fever in the Americas: Guidelines for Prevention and Control Report No. 548 (PAHO, 1997)."},{"key":"2363_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1256-6","volume":"15","author":"A Gordon","year":"2015","unstructured":"Gordon, A. et al. The Nicaraguan pediatric influenza cohort study: design, methods, use of technology, and compliance. BMC Infect. Dis. 15, 504 (2015).","journal-title":"BMC Infect. Dis."},{"key":"2363_CR49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/aje\/kwp092","volume":"170","author":"G Kuan","year":"2009","unstructured":"Kuan, G. et al. The Nicaraguan Pediatric Dengue Cohort Study: study design, methods, use of information technology, and extension to other infectious diseases. Am. J. Epidemiol. 170, 120\u2013129 (2009).","journal-title":"Am. J. Epidemiol."},{"key":"2363_CR50","doi-asserted-by":"publisher","first-page":"e1397","DOI":"10.1371\/journal.pntd.0001397","volume":"5","author":"F Narvaez","year":"2011","unstructured":"Narvaez, F. et al. Evaluation of the traditional and revised WHO classifications of dengue disease severity. PLoS Negl. Trop. Dis. 5, e1397 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2363_CR51","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01785-17","volume":"56","author":"A Balmaseda","year":"2018","unstructured":"Balmaseda, A. et al. Comparison of four serological methods and two reverse transcription-PCR assays for diagnosis and surveillance of Zika virus infection. J. Clin. Microbiol. 56, e01785-17 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"2363_CR52","doi-asserted-by":"publisher","first-page":"e2116","DOI":"10.1371\/journal.pntd.0002116","volume":"7","author":"JJ Waggoner","year":"2013","unstructured":"Waggoner, J. J. et al. Single-reaction, multiplex, real-time RT-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl. Trop. Dis. 7, e2116 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2363_CR53","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3201\/eid2207.160326","volume":"22","author":"JJ Waggoner","year":"2016","unstructured":"Waggoner, J. J. et al. Single-reaction multiplex reverse transcription PCR for detection of Zika, chikungunya, and dengue viruses. Emerg. Infect. Dis. 22, 1295\u20131297 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"2363_CR54","doi-asserted-by":"publisher","first-page":"e1002726","DOI":"10.1371\/journal.pmed.1002726","volume":"16","author":"A Gordon","year":"2019","unstructured":"Gordon, A. et al. Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua. PLoS Med. 16, e1002726 (2019).","journal-title":"PLoS Med."},{"key":"2363_CR55","doi-asserted-by":"crossref","unstructured":"Cohen, J. Statistical Power Analysis for the Behavioral Sciences (Lawrence Erlbaum Associates, 2013).","DOI":"10.4324\/9780203771587"},{"key":"2363_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115613","volume":"44","author":"AG Dias","year":"2025","unstructured":"Dias, A. G. et al. Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease. Cell Rep. 44, 115613 (2025).","journal-title":"Cell Rep."},{"key":"2363_CR57","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1126\/sciadv.abg4084","volume":"7","author":"ST Kudlacek","year":"2021","unstructured":"Kudlacek, S. T. et al. Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies. Sci. Adv. 7, 4084\u20134099 (2021).","journal-title":"Sci. Adv."},{"key":"2363_CR58","doi-asserted-by":"publisher","unstructured":"Cardona-Ospina, J. A. Antibody profiling and regularization model for pre-secondary DENV2 sera post-primary ZIKV infection\u2014Pediatric Dengue Cohort Study. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14837883 (2025).","DOI":"10.5281\/zenodo.14837883"},{"key":"2363_CR59","doi-asserted-by":"publisher","unstructured":"Cardona-Ospina, J. A. Avidity index analysis and regularization model for pre-DENV2 sera post-primary ZIKV infection. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14837889 (2025).","DOI":"10.5281\/zenodo.14837889"},{"key":"2363_CR60","doi-asserted-by":"publisher","unstructured":"Cardona-Ospina, J. A. Post-Zika anti-NS1 serum IgA drives increased neutrophil functions in severe dengue disease. Zenodo https:\/\/doi.org\/10.5281\/zenodo.14837915 (2025).","DOI":"10.5281\/zenodo.14837915"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02363-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02363-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02363-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T17:03:48Z","timestamp":1782147828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02363-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2363"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02363-9","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article was originally published under the subscription model but it is now published under an Open Access license.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.H.\u2019s laboratory received research funds from Takeda Vaccines Inc. to test samples from vaccine recipients. E.H. served on one-time advisory boards for Merck and Takeda. G.A. was an employee of Moderna Therapeutics and holds equity in Leyden Labs and Systems Seromyx. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}